For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Feb 14, 2026  2 hours, 26 minutes ago

Anelloviruses as Markers of Immunity in HIV

5710 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Anelloviruses as Markers of Immunity in HIV
Nikhil Prasad  Fact checked by:Thailand Medical News Team Feb 14, 2026  2 hours, 26 minutes ago
Medical News: Tiny Viruses That Mirror the Immune System
A new scientific review has shed light on a group of little-known viruses that quietly live inside almost every human being. These viruses, called anelloviruses, may actually serve as powerful indicators of how strong or weak a person’s immune system is—especially in individuals living with HIV.
 
The study, led by researchers from the Federal Research Center of Fundamental and Translational Medicine and the State Research Center of Virology and Biotechnology ‘Vector’, explores how these viruses behave during HIV infection and treatment.
 
Anelloviruses are not known to cause disease on their own. Instead, they exist quietly in the body, forming what scientists call an “anellome”—a personal collection of these viruses unique to each individual. This Medical News report highlights how changes in this viral community can reflect the immune system’s condition.
 
What Happens During HIV Infection
HIV primarily attacks CD4+ T cells, which are critical for immune defense. As these cells decline, the immune system weakens. The review explains that when HIV infection is untreated, levels of anelloviruses—especially a type known as Torque teno virus (TTV)—rise dramatically in the blood.
 
Researchers found that higher TTV levels strongly correlate with higher HIV viral loads and lower CD4+ T-cell counts. In simple terms, the weaker the immune system becomes, the more these tiny viruses multiply. Their increase is so consistent that scientists believe measuring anellovirus levels could offer a sensitive way to track immune decline.
 
The Impact of Antiretroviral Therapy
When patients begin antiretroviral therapy (ART), HIV levels drop and CD4+ counts usually improve. The review shows that anellovirus levels also decrease after ART begins. However, they often do not return to the levels seen before HIV infection.
 
Interestingly, patients who start treatment with very high TTV levels may experience incomplete immune recovery, even if HIV becomes undetectable. This suggests that measuring anellovirus load before and during therapy could help identify individuals at risk of poor immune restoration.
 
How These Viruses Interact with Immunity
The review explains that anelloviruses have a complex relationship with the immune system. On one hand, they can activate immune pathways, triggering inflammatory responses. On the other, they produce proteins that can dampen inflammation by interfering with key signaling pathways like NF-κB.
 
This dual behavior means anelloviruses are not just passive markers. They may actively influence immune balance, especially in the chronically inflamed environment seen in HIV infection.
 
The researchers emphasize that monitoring both the amount and diversity of anelloviruses could provide a non-invasive way to assess immune competence. Since these viruses are present in nearly everyone, they offer a universal biological indicator that could complement traditional tests like CD4 counts and HIV viral load measurements.
 
A New Tool for Personalized HIV Care
The review concludes that anello viruses represent a promising biomarker for understanding immune health in people living with HIV. Their levels rise when immune control weakens and fall when immune function improves, making them sensitive indicators of immune dynamics. Although more research is needed to translate these findings into routine clinical practice, monitoring the “anellome” could one day help doctors better predict treatment outcomes, personalize therapy, and detect hidden immune dysfunction even when standard laboratory tests appear normal.
 
The study findings were published in the peer reviewed journal: Viruses.
https://www.mdpi.com/1999-4915/18/2/235
 
For the latest HIV research, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/articles/hiv-aids
 
https://www.thailandmedical.news/articles/immunology
 

MOST READ

Feb 11, 2026  3 days ago
Nikhil Prasad
Feb 09, 2026  5 days ago
Nikhil Prasad
Feb 08, 2026  6 days ago
Nikhil Prasad
Feb 08, 2026  6 days ago
Nikhil Prasad
Feb 06, 2026  8 days ago
Nikhil Prasad
Feb 04, 2026  10 days ago
Nikhil Prasad
Feb 02, 2026  12 days ago
Nikhil Prasad
Feb 01, 2026  13 days ago
Nikhil Prasad
Jan 31, 2026  14 days ago
Nikhil Prasad
Jan 27, 2026  18 days ago
Nikhil Prasad
Jan 27, 2026  18 days ago
Nikhil Prasad
Jan 26, 2026  19 days ago
Nikhil Prasad
Jan 25, 2026  20 days ago
Nikhil Prasad
Jan 24, 2026  21 days ago
Nikhil Prasad
Jan 23, 2026  23 days ago
Nikhil Prasad
Jan 22, 2026  23 days ago
Nikhil Prasad
Jan 21, 2026  24 days ago
Nikhil Prasad
Jan 20, 2026  25 days ago
Nikhil Prasad